ArticleEClinicalMedicine2025
Risk conditions for invasive pneumococcal disease in adults: a systematic review and meta-analysis.
Article in EClinicalMedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Pneumococcal vaccination awareness and uptake among high-risk patients attending internal medicine outpatient clinics: A cross-sectional study.Human vaccines & immunotherapeutics · 2026Article
- Indirect Effect of Pneumococcal Conjugate Vaccines on Pneumococcal Colonization: Persistence and Dynamics of Vaccine Serotypes in Sicily (Italy) 11 Years Postintroduction, 2009-2020.The Journal of infectious diseases · 2026Article
- Improving pneumococcal vaccination uptake in a residency clinic: a case-inspired QI initiative aligned with updated CDC guidelines.BMJ open quality · 2026Article
- Review
- Vaccination Against Respiratory Infections in Adults with Cancer: A Concise Guide for Clinicians.Vaccines · 2026Review
- Article
- Molecular Epidemiology, Antimicrobial Resistance, and Clinical Characteristics ofAntibiotics (Basel, Switzerland) · 2025Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The burden of invasive pneumococcal disease (IPD) in adults remains high despite vaccination programs. Age is currently the prime criterion used to define target groups for prevention. To support effective intervention programs, we investigated the relative importance of risk conditions associated with adult IPD. Methods: We conducted a systematic search in PubMed and Embase and included all original studies published before March 24th 2025 that reported risk estimates for adult IPD in individuals with risk conditions, compared to the general population (PROSPERO ID 417980). Risk estimates were extracted and meta-analyses were performed for conditions supported by more than one study. Pooled incidence rate ratios with 95% confidence intervals (IRRs (95% CIs)) were calculated as the primary outcome using random-effects models. The risk of bias and the certainty of the evidence were assessed using the ROBINS-E tool and GRADE system respectively. Findings: Of the 2983 reports screened, 58 were included in the systematic review, and 46 supported the meta-analyses. More than 50 different risk conditions for adult IPD were identified, which we synthesized in 22 risk domains for meta-analyses. The highest IRRs (95% CIs) for adult IPD were reported in immunocompromising conditions: transplant recipients 30.75 (17.64-53.60), asplenia 24.29 (18.63-31.65), people living with human immunodeficiency virus (PLWH) 21.87 (15.72-30.43), and haematological malignancy 19.63 (11.10-34.71). Increasing age itself mediated minor risk sizes. At lower age the risk conditions conferred relatively higher risk ratios. Chronic kidney disease in adults <65 years old posed an IRR (95% CI) of 18.40 (11.38-29.74), compared to 5.12 (2.08-12.63) among those over 65. IRRs >10 were also observed for compromised cerebrospinal fluid barrier and Down syndrome. The overall quality of evidence was very low, mainly due to high risk of bias and considerable between-study heterogeneity. Several studies suggested cumulative risk in individuals with multimorbidity, although data on interactions between conditions were limited. Interpretation: This systematic review and meta-analysis quantify the relative importance of risk conditions for adult IPD. Understanding how these risk conditions interact in cases of multimorbidity remains an important area for future research. Funding: Radboudumc Community for Infectious Diseases encouragement Grant.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.